Advertisement

Loading...

LBT Innovations Limited

LBT.AXASX
Healthcare
Medical - Devices
$0.02
$0.00(0.00%)
Australian Market is Open • 15:49

LBT Innovations Limited Fundamental Analysis

LBT Innovations Limited (LBT.AX) shows weak financial fundamentals with a PE ratio of -4.27, profit margin of -2.98%, and ROE of -3.23%. The company generates $0.0B in annual revenue with weak year-over-year growth of -41.09%.

Key Strengths

Cash Position14.71%
PEG Ratio-0.04
Current Ratio3.62

Areas of Concern

ROE-3.23%
Operating Margin-3.77%
We analyze LBT.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -570.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-570.3/100

We analyze LBT.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

LBT.AX struggles to generate sufficient returns from assets.

ROA > 10%
-47.16%

Valuation Score

Excellent

LBT.AX trades at attractive valuation levels.

PE < 25
-4.27
PEG Ratio < 2
-0.04

Growth Score

Moderate

LBT.AX shows steady but slowing expansion.

Revenue Growth > 5%
-41.09%
EPS Growth > 10%
91.63%

Financial Health Score

Moderate

LBT.AX shows balanced financial health with some risks.

Debt/Equity < 1
1.32
Current Ratio > 1
3.62

Profitability Score

Weak

LBT.AX struggles to sustain strong margins.

ROE > 15%
-322.69%
Net Margin ≥ 15%
-2.98%
Positive Free Cash Flow
No

Key Financial Metrics

Is LBT.AX Expensive or Cheap?

P/E Ratio

LBT.AX trades at -4.27 times earnings. This suggests potential undervaluation.

-4.27

PEG Ratio

When adjusting for growth, LBT.AX's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values LBT Innovations Limited at 6.58 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.58

EV/EBITDA

Enterprise value stands at -7.17 times EBITDA. This is generally considered low.

-7.17

How Well Does LBT.AX Make Money?

Net Profit Margin

For every $100 in sales, LBT Innovations Limited keeps $-2.98 as profit after all expenses.

-2.98%

Operating Margin

Core operations generate -3.77 in profit for every $100 in revenue, before interest and taxes.

-3.77%

ROE

Management delivers $-3.23 in profit for every $100 of shareholder equity.

-3.23%

ROA

LBT Innovations Limited generates $-47.16 in profit for every $100 in assets, demonstrating efficient asset deployment.

-47.16%

Following the Money - Real Cash Generation

Operating Cash Flow

LBT Innovations Limited generates limited operating cash flow of $-6.88M, signaling weaker underlying cash strength.

$-6.88M

Free Cash Flow

LBT Innovations Limited generates weak or negative free cash flow of $-6.89M, restricting financial flexibility.

$-6.89M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

LBT.AX converts -12.31% of its market value into free cash.

-12.31%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.27

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

23.80

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.32

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.62

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.23

vs 25 benchmark

ROA

Return on assets percentage

-0.47

vs 25 benchmark

ROCE

Return on capital employed

-0.74

vs 25 benchmark

How LBT.AX Stacks Against Its Sector Peers

MetricLBT.AX ValueSector AveragePerformance
P/E Ratio-4.2728.31 Better (Cheaper)
ROE-322.69%699.00% Weak
Net Margin-297.77%-130884.00% (disorted) Weak
Debt/Equity1.320.34 Weak (High Leverage)
Current Ratio3.622775.16 Strong Liquidity
ROA-47.16%-14469.00% (disorted) Weak

LBT.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews LBT Innovations Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

29.63%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

73.47%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-40.46%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ